Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE4518.00-53.9 (-1.18 %)
PREV CLOSE () 4571.90
OPEN PRICE () 4599.80
BID PRICE (QTY) 4513.15 (1)
OFFER PRICE (QTY) 4517.50 (29)
VOLUME 3703
TODAY'S LOW / HIGH ()4503.45 4599.80
52 WK LOW / HIGH ()3103 4714.5
NSE4507.40-65.2 (-1.43 %)
PREV CLOSE() 4572.60
OPEN PRICE () 4572.30
BID PRICE (QTY) 4505.60 (12)
OFFER PRICE (QTY) 4507.40 (26)
VOLUME 41803
TODAY'S LOW / HIGH() 4503.80 4595.20
52 WK LOW / HIGH ()3102 4712.9
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1972

Management Info :

Samir Mehta - Chairman Aman Mehta - Managing Director

Registered Office :

Address : Avirat,Thaltej Shilaj Road, ,
Ahmedabad,
Gujarat-380059

Phone : 079-26599000

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
25May Torrent Pharma’s consolidated net prof
Torrent Pharmaceuticals has reported results for the fourth quarter (Q4F..
25May Torrent Pharma jumps despite consolida
Torrent Pharmaceuticals is currently trading at Rs. 4562.70, up by 78.55..
13Apr USFDA concludes inspection at Torrent
U.S. Food and Drug Administration (USFDA) has concluded the inspection a..
21Mar Torrent Pharmaceuticals launches Semag
Torrent Pharmaceuticals has launched its Semaglutide brands - Sembolic a..
13Feb Torrent Pharmaceuticals reports 26% ri
Torrent Pharmaceuticals has reported results for third quarter ended Dec..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit467021920
Gross Profit 5920 28970
Operating Profit 1061040720
Net Sales 27350107120
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 17088.45 (2.07%)
M.Cap ( in Cr)
21940.07
Acutaas Chemicals (BSE)
 3027.35 (3.68%)
M.Cap ( in Cr)
24838.06
Alivus Life Sciences (BSE)
 1110.85 (6.00%)
M.Cap ( in Cr)
13501.34
Wockhardt (BSE)
 1701.45 (3.79%)
M.Cap ( in Cr)
27735.79
Bliss GVS Pharma (BSE)
 369.55 (16.36%)
M.Cap ( in Cr)
3945.40
Shareholding Pattern
PROMOTERS 68.31%
NON-INSTITUTION 6.45%
MUTUAL FUNDS/UTI 4.45%
FI/BANKS/INSURANCE 1.97%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX76506.7217.76 (0.02%)
NIFTY24028.75-2.95 (-0.01%)
Dow Jones 50579.70294.04 (0.58%)
Nasdaq 26343.9750.87 (0.19%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI